DM
Daniel Markowitz Evercore ISI Group Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
30
Avg Return
Past Year
Past Year
2.1%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
77.8%
Neutral
22.2%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Healthcare
Technology
Healthcare
Biotechnology
Diagnostics & Research
Medical Devices
Medical Instruments & Supplies
Technology
Semiconductors
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $260 |
20%
upside
| 3 | +14% |
0
%
| 27 Feb ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $170 |
125%
upside
| 2 | +5.4% |
0
%
| 25 Feb ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $170 |
30%
upside
| 5 | -0.75% |
0
%
| 25 Feb ‘26 3 months ago |
|
|
|
In-Line
Maintained
| $110 |
15%
downside
| 4 | +27% |
0
%
| 20 Feb ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $340 |
130%
upside
| 2 | -12% |
0
%
| 19 Feb ‘26 3 months ago |
|
|
|
In-Line
Maintained
| $68 |
21%
upside
| 4 | -2.4% |
0
%
| 5 Feb ‘26 4 months ago |
|
|
|
Outperform
Maintained
| $320 |
3%
downside
| 4 | +1.7% |
0
%
| 3 Feb ‘26 4 months ago |
|
|
|
Outperform
Maintained
| $119 |
17%
downside
| 3 | +1.4% |
0
%
| 3 Feb ‘26 4 months ago |
|
|
|
In-Line
Initiated
| $68 |
8%
downside
| 1 | – |
–
| 25 Nov ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $125 |
204%
upside
| 2 | -20% |
0
%
| 7 Oct ‘25 8 months ago |
|